Literature DB >> 34887569

CSN5 as a clinical target in prostate cancer.

Maria Chiara Masone1.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 34887569     DOI： 10.1038/s41585-021-00552-3

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Prognostic and therapeutic significance of COP9 signalosome subunit CSN5 in prostate cancer.

Authors:  Ying Z Mazzu; Yu-Rou Liao; Subhiksha Nandakumar; Lina E Jehane; Richard P Koche; Sai Harisha Rajanala; Ruifang Li; HuiYong Zhao; Travis A Gerke; Goutam Chakraborty; Gwo-Shu Mary Lee; Gouri J Nanjangud; Anuradha Gopalan; Yu Chen; Philip W Kantoff
Journal:  Oncogene       Date:  2021-11-20       Impact factor: 8.756
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.